Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis
09:00am, Friday, 09'th May 2025
PHILADELPHIA--(BUSINESS WIRE)-- #Adolescents--GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis.
GSK price target lowered to 1,355 GBp from 1,450 GBp at Morgan Stanley
01:23pm, Wednesday, 07'th May 2025
Morgan Stanley lowered the firm's price target on GSK to 1,355 GBp from 1,450 GBp and keeps an Underweight rating on the shares.
5 Reasons GSK Looks Good
11:37am, Monday, 05'th May 2025
GSK's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 numbers. Both turnover and EPS growth exceeded expectations, and the company's guidan
Here's Why GSK (GSK) is a Strong Growth Stock
10:46am, Thursday, 01'st May 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance
12:46pm, Wednesday, 30'th Apr 2025
GSK reports mixed first-quarter 2025 results. Shares rise in pre-market after it reaffirms guidance and says it is "well positioned" to handle the U.S. tariffs.
GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript
12:32pm, Wednesday, 30'th Apr 2025
GSK plc (NYSE:GSK ) Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ET Company Participants Constantin Fest - Head of IR Emma Walmsley - CEO Luke Miels - Chief Commercial Officer Julie Brown -
Here's Why GSK (GSK) is a Strong Momentum Stock
10:55am, Wednesday, 30'th Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Cervarix market report offers a comprehensive analysis of market size, growth potential, and segmentation, highlighting trends across major regions. Key drivers include rising HPV awareness, vacci
Britain's GSK Asserts It Is 'Well Positioned' To Mitigate Potential Tariffs After Strong Q1 Cancer And HIV Drug Sales
09:27am, Wednesday, 30'th Apr 2025
On Wednesday, British multinational pharmaceutical GSK Plc GSK reported first-quarter sales of $9.46 billion (7.52 billion Sterling Pounds), up 2% year-over-year and 4% on constant currency. Analysts�
GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs
09:12am, Wednesday, 30'th Apr 2025
GSK stock jumped early Wednesday after the drugmaker reported adjusted earnings of $1.20 per share on $10.06 billion in first-quarter sales.
GSK Posts Strong Results, Says 'Well Positioned' in Case of Pharma Tariffs
09:06am, Wednesday, 30'th Apr 2025
U.S.-listed shares of GSK (GSK) are gaining in premarket trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the
GSK: Disproportionately discounted, but earnings beat shows signs of reappraisal
08:46am, Wednesday, 30'th Apr 2025
Shore Capital is sticking with its upbeat view on GSK PLC (LSE:GSK, NYSE:GSK), calling the stock “disproportionately discounted” after first-quarter numbers surpassed expectations and guidance was
GSK (GSK) Q1 Earnings Surpass Estimates
08:06am, Wednesday, 30'th Apr 2025
GSK (GSK) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.09 per share a year ago.
GSK jumps 4% as earnings beat boosts confidence
07:03am, Wednesday, 30'th Apr 2025
GSK PLC (LSE:GSK, NYSE:GSK) shares rose 4% on Tuesday, adding £2.6 billion to its market value, after the drugmaker delivered better-than-expected first-quarter results and reiterated full-year guid
GSK beats earnings forecasts despite weaker vaccine sales
03:03am, Wednesday, 30'th Apr 2025
GSK PLC (LSE:GSK, NYSE:GSK) reported earnings ahead of expectations and kept full-year guidance intact, even though sales of vaccines softened. The FTSE 10-listed drugmaker reported a 6.1% fall in va
